Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway
Hongyu Yuan, Zitong Zhao, Jing Xu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Hypoxia promotes histone H3K9 lactylation to enhance LAMC2 transcription in esophageal squamous cell carcinoma
Yong Zang, Yu Wang, Jianji Zhang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110188-110188
Open Access | Times Cited: 7
Revisiting reactive oxygen species production in hypoxia
Ricardo Alva, Jacob E. Wiebe, Jeffrey A. Stuart
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 9, pp. 1423-1444
Closed Access | Times Cited: 5
Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
Dandan Shi, Jiejing Tao, Shuli Man, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189207-189207
Closed Access | Times Cited: 5
Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC)
Linjia Peng, Zixuan Gao, Yan‐Feng Liang, et al.
Nanoscale (2025)
Open Access
Hypoxia exposure induces lactylation of Axin1 protein to promote glycolysis of esophageal carcinoma cells
Qian Li, Guihu Lin, Kaihua Zhang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116415-116415
Closed Access | Times Cited: 4
Targeting esophageal carcinoma: molecular mechanisms and clinical studies
Wenjing Wang, Lisha Ye, Huihui Li, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Induction of LARP1B under endoplasmic reticulum stress and its regulatory role in proliferation of esophageal squamous cell carcinoma
Yang Xia, Juntao Lu, Fangyu Su, et al.
Translational Oncology (2024) Vol. 50, pp. 102141-102141
Open Access | Times Cited: 1
Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)/combretastatin A4/BLZ945 nanoparticles on Renca renal carcinoma
Jiaqi Chen, Min Yin, Chenguang Yang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
Identification and validation of prognostic and immunotherapeutic responses in esophageal squamous carcinoma based on hypoxia phenotype-related genes
Kai Xie, Zhe Chen, Jian Feng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling
Jing Zhou, M Zhang, Aiai Gao, et al.
Epigenomics (2024) Vol. 16, Iss. 13, pp. 929-944
Open Access
Exploration on the Effects and Molecular Mechanisms of Pterostilbene on Esophageal Cancer Based on Network Pharmacology
Guanglin Liu, Xiaolong Yan, Jialing Jiang
Journal of Contemporary Medical Practice (2024) Vol. 6, Iss. 12, pp. 237-241
Closed Access
Page 1

Scroll to top